According to latest estimates from the Budget Lab at Yale, all U.S. tariffs implemented so far this year translate to an ...

SPTS offers low duration risk and ultra-low fees but faces challenges from USD reserve concerns and credit downgrades. Learn ...

EPR Properties' portfolio transition, safe monthly dividend, and strong fundamentals thrives with experiential assets and ...

Instil Bio eyes key NSCLC catalyst with Phase 2 China data in 2H 2025 and a distinct U.S. strategy. Learn why AXN-2510 stands ...

Rapidly rising bond yields are starting to garner more wide-spread attention. Check out four defensive assets that could help ...

Discover why Zillow's stock dip presents a buying opportunity. Strong growth, diversification, and key partnerships position ...

Midstream energy CEFs lag amid economic uncertainty, oil price drops, and tariff risks. See why NML stands out and learn why ...

Aurora Cannabis' strong adjusted EBITDA and low debt position set the stage for potential upside if growth continues. Read ...

Frontdoor is rebounding on strong Q1 results, rising guidance, and solid growth despite housing risks, with sustainable ...

Honeywell is preparing to split into three focused businesses, aiming to unlock shareholder value. Read why I remain in ...

AstraZeneca continues to impress me with the strong performances of its oncology, cardiovascular, and rare disease franchises ...

Coca-Cola Consolidated has shifted from dividends to buybacks, with limited margin upside and uncertain succession ahead.